Showing 561 - 580 results of 1,447 for search '"liver disease"', query time: 0.08s Refine Results
  1. 561

    Effects of celastrol on the heart and liver galaninergic system expression in a mouse model of Western-type diet-induced obesity and metabolic dysfunction-associated steatotic liver disease and steatohepatitis by Nikolina Canová, Jana Šípková, Mahak Arora, Zuzana Pavlíková, Zuzana Pavlíková, Tomáš Kučera, Ondřej Šeda, Tijana Šopin, Tomáš Vacík, Ondřej Slanař

    Published 2025-02-01
    “…Therefore, this study aimed to investigate the effects of celastrol on the galaninergic system expression in the heart and liver of mice suffering from diet-induced obesity and metabolic dysfunction-associated steatotic liver disease and steatohepatitis (MASLD/MASH).MethodsThe male mice C57BL/6J were fed a Western-type high-fat diet for 16 and 20 weeks to induce obesity and MASLD/MASH. …”
    Get full text
    Article
  2. 562

    The Effects of Extra Virgin Olive Oil on Alanine Aminotransferase, Aspartate Aminotransferase, and Ultrasonographic Indices of Hepatic Steatosis in Nonalcoholic Fatty Liver Disease Patients Undergoing Low Calorie Diet by Farzad Shidfar, Samaneh Sadat Bahrololumi, Saeid Doaei, Assieh Mohammadzadeh, Maryam Gholamalizadeh, Ali Mohammadimanesh

    Published 2018-01-01
    “…Coronary artery disease is the most common cause of death in the patients with nonalcoholic fatty liver disease (NAFLD). Studies have shown that there is a strong relation between the increase in the aminotransferase levels and fat accumulation in the liver with cardiovascular complications, independent of all aspects of the metabolic syndrome. …”
    Get full text
    Article
  3. 563
  4. 564
  5. 565
  6. 566
  7. 567
  8. 568
  9. 569

    A Very Low–Carbohydrate Program in Adults With Metabolic Dysfunction–Associated Steatotic Liver Disease and Phospholipase Domain–Containing Protein 3 Risk Genotype: Pre-Post Intervention Study by Laura R Saslow, Jamie Krinock, Alison O'Brien, Kaitlyn Raymond, Hovig Bayandorian, Judith T Moskowitz, Jennifer Daubenmier, Antonino Oliveri, Deanna J Marriott, Dina H Griauzde, Elizabeth K Speliotes

    Published 2025-01-01
    “… Abstract BackgroundInsulin resistance and the G allele of rs738409 interact to create a greater risk of metabolic dysfunction–associated steatotic liver disease. ObjectiveThis study aims to confirm that one promising way to reduce insulin resistance is by following a very low–carbohydrate (VLC) dietary pattern. …”
    Get full text
    Article
  10. 570
  11. 571
  12. 572
  13. 573
  14. 574

    Lipotoxicity and metabolic disorders at obesity by V. T. Ivashkin, M. V. Mayevskaya

    Published 2010-02-01
    Subjects: “…non-alcoholic fatty liver disease…”
    Get full text
    Article
  15. 575
  16. 576
  17. 577
  18. 578
  19. 579
  20. 580